Cookies disclaimer

Continue Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device. Additional information can be found under the cookie section of this page.

Major health care issues in Europe, 2014

Question: What in your opinion are the major health care issues in Europe?

Top 10 answers summarised as the major themes:

  1. Sustainability and costs
    • Example answers: Cost reduction policies; High costs of drug development; Pharmacoeconomics; Inefficient healthcare systems; Sustainability of public sector healthcare
  2. Antibiotics/Infectious disease
    • Example answers: Antibiotic resistance; Gaps in research and development of new antibiotics; Improvement of antibiotics and vaccines
  3. Personalised medicine
    • Example answers: Development of genetics based personal risk assessment; Training of medical personnel including GPs to deliver personalised healthcare solutions to patients
  4. Standardisation and coordination
    • Example answers: Standardising health technology assessments between countries; Poor coordination efforts; Bureaucracy and regulation
  5. Diabetes and Obesity
  6. Age related disease
    • Example answers: Alzheimer’s and other Neurodegenerative diseases; Normal ageing
  7. Cancer
  8. Information technology
    • Example answers: Lack of experts that understand both information technology and healthcare; Enabling data analysis over secure systems; Training in “Big Data” analysis; Gaining permissions to combining and exporting datasets that can be logically integrated
  9. Efficacy and Safety
    • Example answers: Reliable processes for relative effectiveness (HTA) measurement needed; Real world evidence for efficacy and safety
  10. Innovation
    • Example answersLack of truly innovative drugs; Slow rate of discovery of active molecules for solutions to today’s challenges